Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             128 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bioassay for platelet activating factor which uses washed rabbit platelets and the specific antagonist web 2086: Methodological considerations and its application to human tissue samples Heuer, H.
1988
35 5 p. 837-
1 p.
artikel
2 Acceleration of healing in an animal model of inflammatory bowel disease by BN52021 Wallace, J.L.
1988
35 5 p. 813-
1 p.
artikel
3 Activity of a novel anti-thrombotic compound, PCA-4230, on PAF-acether effects Ortega, M.P.
1988
35 5 p. 826-
1 p.
artikel
4 Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease Satoh, Kei
1988
35 5 p. 685-698
14 p.
artikel
5 Activity of the new and specific PAF-antagonists WEB 2170 and STY 2108 on PAF-induced bronchoconstriction and intrathoracic accumulation of platelets in the guinea-pig Heuer, H.
1988
35 5 p. 798-
1 p.
artikel
6 Aggregation of platelets in vivo and bronchial hyperreactivity in response to PAF allows distinction between PAF-receptor antagonists and prophylactic anti-asthma drugs Morley, J.
1988
35 5 p. 820-
1 p.
artikel
7 Anesthesia prevents PAF-acether-induced leukocytosis in rats, but hemoconcentration is maintained Martins, P.M.R.e S.
1988
35 5 p. 835-
1 p.
artikel
8 Anti-inflammatory effects of BN-52021 Lorenzetti, B.B.
1988
35 5 p. 835-
1 p.
artikel
9 A platelet activating factor antagonist inhibits the cerebral blood flow and neurochemical changes caused by cerebral injury-reperfusion Bazan, N.G.
1988
35 5 p. 831-
1 p.
artikel
10 Arachidonic acid metabolites do not mediate toluene diisocyanate-induced airway hyperresponsiveness in Guinea pigs Gordon, Terry
1988
35 5 p. 699-706
8 p.
artikel
11 5-aryl-2 3-dihydroimidazo [2,1-a] isoquinolines. A novel class of platelet-activating factor (PAF) receptor antagonists structurally derived from the PAF molecule Houlihan, W.J.
1988
35 5 p. 848-
1 p.
artikel
12 Benzodiazepine protection against PAF-acether toxicity in mice Zeller, M.
1988
35 5 p. 823-
1 p.
artikel
13 Biochemical and functional evidence for the existence of PAF receptors on human polymorphonuclear leukocytes Marquis, O.
1988
35 5 p. 795-
1 p.
artikel
14 Biological characterization of the enantiomeric hetrazepines of the paf-antagonist web 2170 Heuer, H.
1988
35 5 p. 847-
1 p.
artikel
15 BN 52021 and specific binding sites for platelet activating factor (PAF) in brain and eyes Domingo, M.T.
1988
35 5 p. 815-
1 p.
artikel
16 BN 52021, inhibition of free polyunsaturated fatty acid accumulation in mouse brain during electroconvulsive shock and ischemia Birkle, D.L.
1988
35 5 p. 816-
1 p.
artikel
17 BN 52021 inhibits glomerular and mesangial cell contraction induced by cyclosporin A (CSA) Rodriguez-Puyol, D.
1988
35 5 p. 810-
1 p.
artikel
18 BN 52021 pretreatment protects against glycerol induced acute renal failure Lopez-Novoa, JM
1988
35 5 p. 811-
1 p.
artikel
19 Cardiovascular profile of 59227 RP, a novel potent and specific PAF receptor antagonists Mondot, S.
1988
35 5 p. 827-
1 p.
artikel
20 Cationic lipid PAF antagonists. Examination of a strategy to improve oral activity Tomesch, J.
1988
35 5 p. 844-
1 p.
artikel
21 Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats Kochabek, P.M.
1988
35 5 p. 830-
1 p.
artikel
22 Comparison of systemic and local eosinophil recruitment induced by PAF or immune challenge in the rat: Modulation by drugs Etienne, A.
1988
35 5 p. 804-
1 p.
artikel
23 Cytotoxic activity of non-charged platelet-activating factor (PAF) antagonists against murine tumor cell lines Houlihan, W.J.
1988
35 5 p. 817-
1 p.
artikel
24 Drug modulation of human neutrophil activation by PAF-acether Rubino, A.
1988
35 5 p. 796-
1 p.
artikel
25 Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and tumor necrosis factor induced changes in mortality and intestinal transit velocity Heuer, H.
1988
35 5 p. 814-
1 p.
artikel
26 Effect of a PAF analog on phospholipase activity and PAF responses Kohler, C.
1988
35 5 p. 843-
1 p.
artikel
27 Effect of intravenous or inhalative web 2086 on ex vivo platelet activating factor induced platelet aggregation in man Adamus, W.S.
1988
35 5 p. 797-
1 p.
artikel
28 Effect of PAF-acether and endotoxin on rat mesenteric microvessels; inhibition by specific antagonists Lagente, V.
1988
35 5 p. 808-
1 p.
artikel
29 Effect of PAF and PAF antagonists on hypothalamic neuropeptides release Rougeot, C.
1988
35 5 p. 816-
1 p.
artikel
30 Effect of PAF antagonists and cyclosporine on interstitium in infiltrating cells in experimental nephrosis Egido, J.
1988
35 5 p. 810-
1 p.
artikel
31 Effect of peroral web 2086 on ex vivo platelet activating factor induced platelet aggregation in man Adamus, W.S.
1988
35 5 p. 836-
1 p.
artikel
32 Effect of platelet-activating factor (PAF) on monocyte activation and production of tumor necrosis factor (TNF) Bonavida, B.
1988
35 5 p. 802-
1 p.
artikel
33 Effect of three chinese herbal medicines(ligustrazine, chrysanthemum indicum, salviae miltiorrhizae) on PAF and ADP-induced platelet aggregation in vitro Levy, J.V.
1988
35 5 p. 842-
1 p.
artikel
34 Effects of a PAF-antagonists and a cortcosteroid on cardiac transplant and native atherosclerosis in rabbits Foegh, M.
1988
35 5 p. 805-
1 p.
artikel
35 Effects of new chemically and metabolically stable prostacyclin analogues (iloprost and ZK 96480) on early consequences of a transient cerebral oligemia, in the rat M.G., Borzeix
1988
35 5 p. 653-664
12 p.
artikel
36 Effects of PAF antagonists on platelet behaviour and arrhythmias during myocardial ischaemia Wainwright, C.L.
1988
35 5 p. 809-
1 p.
artikel
37 Effects of PAF antagonists on renal vascular escape and tachyphylaxis in the isolated prefused rabbit kidney Fonteles, M.C.
1988
35 5 p. 827-
1 p.
artikel
38 Hemostasis changes induced by soluble aggregates of immunoglobulin G (IgG) in the rat. Studies with the PAF antagonist BN 52021 Fernandez-Gallardo, S.
1988
35 5 p. 805-
1 p.
artikel
39 Histological and radiological assessment of neutrophil and platelet responses to PAF in vivo Walker, J.R.
1988
35 5 p. 841-
1 p.
artikel
40 Immune complex induced pancreatitis: Effect of BN 52021, a selective antagonist of platelet-activating factor Jancar, Sonia
1988
35 5 p. 757-770
14 p.
artikel
41 Inflammatory activity of a crude extract of coelenterate tentacles (Dactilometra) and the possible PAF-acether involvement Cordeiro, R.S.B.
1988
35 5 p. 836-
1 p.
artikel
42 Influence of anaesthetics on PAF-acether-induced death in mice Subissi, A.
1988
35 5 p. 834-
1 p.
artikel
43 Influence of BN 52021 on the cardio- and hemodynamic changes during deveplopment of the postischemic shock reaction Sagach, V.F.
1988
35 5 p. 812-
1 p.
artikel
44 Inhibition of arachidonic acid(AA)-induced contraction of guinea pig airways in vitro and in vivo by various inhibitors of phospholipid mediator synthesis Slapke, J.
1988
35 5 p. 821-
1 p.
artikel
45 Inhibition of gastric motility changes following PAF-acether and endotoxin by L-652, 731 Esplugues, J.V.
1988
35 5 p. 829-
1 p.
artikel
46 Inhibition of PAF-induced effects in the guinea pig right atrium by BN 52021 and somatostatin Hellegouarch, A.
1988
35 5 p. 826-
1 p.
artikel
47 Inhibition of PAF-induced vascular permeability in rats, by the PAF-antagonist WEB 2086 and WEB 2170 Muacevic, G.
1988
35 5 p. 839-
1 p.
artikel
48 Inhibition of the binding and aggregation to PAF in vitro in comparison with PAF-antagonism in vivo: An investigation using different types of PAF-antagonists Heuer, H.
1988
35 5 p. 838-
1 p.
artikel
49 Inhibitory action of WEB-2086 (a thieno-triazolodiazepine) and its cyclohexyl analog (WEB-2118) on platelet activating factor(PAF) induced aggregation of human platelets in whole blood Levy, J.V.
1988
35 5 p. 841-
1 p.
artikel
50 Interaction between PAF-acether and thromboxane in endotoxin-induced intestinal damage Whittle, B.J.R.
1988
35 5 p. 813-
1 p.
artikel
51 Interaction of fenoterol and web 2086 with propranolol morality in mice and broncho-constriction in the guinea pig to PAF-acether Huber, H.
1988
35 5 p. 850-
1 p.
artikel
52 Interactions between phospholipidic model membranes and two PAF antagonists, ginkgolides BN 52021 and BN 52024: An ESR-spin labelling study Vachon, A.
1988
35 5 p. 849-
1 p.
artikel
53 Interactions of hetrazepines with the central benzodiazepine receptor and the PAF receptor Weber, K.H.
1988
35 5 p. 847-
1 p.
artikel
54 Interference of ginkgolides with the rise in intraocular pressure after laser irradiation of the iris in the rabbit eye Verbey, N.L.J.
1988
35 5 p. 832-
1 p.
artikel
55 Interference of PAF-acether antagonists with the hyperresponsiveness to PAF-acether of lungs from actively sensitized guinea-pigs Pretolani, M.
1988
35 5 p. 800-
1 p.
artikel
56 Interference of the PAF-acether antagonist Ro 19–3704 with PAF-acether and FMLP-induced superoxide anion and thromboxane B2 generation by guinea-pig alveolar macrophages and rabbit neutrophils Desquand, S.
1988
35 5 p. 820-
1 p.
artikel
57 In vitro and in vivo effects of SM-10661, a newly synthesized platelet-activating factor (PAF) antagonist Morooka, S.
1988
35 5 p. 840-
1 p.
artikel
58 In vivo human platelet PAF receptor occupancy by WEB 2086: correlation with inhibition of platelet aggregation and WEB 2086 plasma levels Birke, F.W.
1988
35 5 p. 839-
1 p.
artikel
59 Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils Spinnewyn, B.
1988
35 5 p. 815-
1 p.
artikel
60 Involvement of platelet-activating factor (PAF) in corneal anterior segment inflammation Bazan, H.E.P.
1988
35 5 p. 832-
1 p.
artikel
61 iS Zn2+ a mediator of cellular responses?. A study in rat thymocytes Senn, N.
1988
35 5 p. 819-
1 p.
artikel
62 Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (rosaprostol) Benfenati, E.
1988
35 5 p. 665-684
20 p.
artikel
63 Mechanisms and pharmacological modulation of PAF-acether-induced death in mice Criscuoli, M.
1988
35 5 p. 822-
1 p.
artikel
64 Neutrophils induce platelet activation in rabbit and human: A role for PAF-acether only in rabbit Coëffier, E.
1988
35 5 p. 794-
1 p.
artikel
65 New strategies for the synthesis of sulfur substituted PAF analogues Hajdu, J.
1988
35 5 p. 848-
1 p.
artikel
66 Optimisation for a viable [3H]PAF binding to human platelet membranes Tahraoui, L.
1988
35 5 p. 794-
1 p.
artikel
67 Oxytocin stimulates the release of arachidonic acid and prostaglandin F2α from human decidual cells Wilson, T.
1988
35 5 p. 771-780
10 p.
artikel
68 PAF-acether antagonists and LTC4 formation by human eosinophils Bruijnzeel, P.L.B.
1988
35 5 p. 843-
1 p.
artikel
69 PAF-acether autogenerated in the guinea-pig arterial wall may account for local thromboformation Bourgain, R.
1988
35 5 p. 809-
1 p.
artikel
70 PAF-acether chemotactic activity on neutrophils in bronchial asthma. Effects of specific PAF-acether antagonists Rabier, M.
1988
35 5 p. 795-
1 p.
artikel
71 PAF-acether enhances the production of tumor necrosis factor by human and rodent lymphocytes and macrophages Rola-Pleszczynski, M.
1988
35 5 p. 802-
1 p.
artikel
72 PAF-acether in the carrageenan-induced inflammatory reaction in mice Henriques, M.G.M.O.
1988
35 5 p. 840-
1 p.
artikel
73 PAF-acether-PGE2 interactions in guinea-pig tracheal preparations Brunelleschi, S.
1988
35 5 p. 849-
1 p.
artikel
74 PAF antagonism in renal ischemia Plante, G.E.
1988
35 5 p. 828-
1 p.
artikel
75 PAF-antagonists and thromboxane (TX) antagonists abolish PAF-induced cardiac rhythym disturbances Mest, H.-J.
1988
35 5 p. 807-
1 p.
artikel
76 PAF antagonists protect mice against lethality caused by active anphylactic shock Sedivy, P.
1988
35 5 p. 823-
1 p.
artikel
77 PAF antagonists SDZ 63–441 and SDZ 63–675. Synthesis of and pharmacological characterization of the individual enantiomers Tomesch, J.
1988
35 5 p. 845-
1 p.
artikel
78 PAF enhances erytrophagocytic activity of human monocytes by the protein kinase C dependent phosphorylation of C3b receptor (CR1). Role of PAF receptor antagonists Bussolino, F.
1988
35 5 p. 803-
1 p.
artikel
79 PAF increases vascular permeability in selected tissues: Effect of BN52021 and L-655,240 Sirois, P.
1988
35 5 p. 798-
1 p.
artikel
80 PAF-induced airway hyperresponsiveness: Effect on contractility of guinea-pig trachea Giorgetti, C.
1988
35 5 p. 822-
1 p.
artikel
81 PAF-induced edema and bronchoconstriction in the perfused lung Tozzi, S.
1988
35 5 p. 799-
1 p.
artikel
82 PAF-induced platelet response is enhanced by polymorphonuclear leukocytes (PMN) Del Maschio, A.
1988
35 5 p. 818-
1 p.
artikel
83 PAF stimulates arachidonic acid metabolism in rat liver cells by a receptor-mediated mechanism Levine, L.
1988
35 5 p. 796-
1 p.
artikel
84 Pharmacological modulation of PAF-acether-induced pleuresy in rats and its relevance for inflammation by zymosan R.S.B., Cordeiro
1988
35 5 p. 801-
1 p.
artikel
85 Pharmacological profile of a novel potent and specific PAF receptor antagonist, the 59227 RP Robaut, C.
1988
35 5 p. 838-
1 p.
artikel
86 Pharmacological studies on dithranol-induced dermatitis Kemeny, L.
1988
35 5 p. 834-
1 p.
artikel
87 Platelet activating factor induced inflammatory responses in the skin Sciberras, D.G.
1988
35 5 p. 833-
1 p.
artikel
88 Platelet-activating factor (PAF) causes goblet cell depletion in addition to inflammatory effects on the conjunctiva Woodward, D.F.
1988
35 5 p. 833-
1 p.
artikel
89 Platelet activating factor (PAF) stimulates a phospholipase C (PLC) in differentiated human monocytic leukemia (U-937) cells, resulted in phosphoinositide (PI) hydrolysis and introcellular calcium ([Ca2+]i) mobilization Barzaghi, Giovanna
1988
35 5 p. 819-
1 p.
artikel
90 Platelet-activating factor receptor blockade decreases early post-traumatic cerebral edema in rats Buchanan, D.C.
1988
35 5 p. 814-
1 p.
artikel
91 Platelet aggregation in asthma Palma-Carlos, A.G.
1988
35 5 p. 801-
1 p.
artikel
92 Potentiation of the immunosuppressive action of cyclosporine a (CSA) by the platelet-activating factor (PAF) antagonist, BN 52063 B., Pignol
1988
35 5 p. 824-
1 p.
artikel
93 Presence of specific platelet-activating factor (PAF) binding sites in the mammalian retina and their implication for visual function Doly, M.
1988
35 5 p. 830-
1 p.
artikel
94 Prolongation of experimental liver xenograft survival using a PAF antagonist Filipponi, F.
1988
35 5 p. 806-
1 p.
artikel
95 Protection by BN 52021, a PAF receptor antagonist of ischemia-induced arrhythmias in isolated working rat hearts Tosaki, A.
1988
35 5 p. 851-
1 p.
artikel
96 Protein kinase C and the PAF cycle in the cornea Bazan, N.G.
1988
35 5 p. 831-
1 p.
artikel
97 Rearrangement of 5S, 12S-dihydroxy-6,8,10,14-(E,Z,E,Z)-eicosatetraenoic acid during gas chromatography: formation of a cyclohexadiene derivative Borgeat, Pierre
1988
35 5 p. 723-731
9 p.
artikel
98 Renal microcirculation during plateler-activating factor (PAF) antagonist (BN) administration Santos, OFP.
1988
35 5 p. 828-
1 p.
artikel
99 Role of platelet-activating factor (PAF) in ovoimplantation and decidualization process in the rat Acker, G.M.
1988
35 5 p. 817-
1 p.
artikel
100 Specific leukotriene D4 receptors on guinea-pig alveolar macrophages Cristol, J.P.
1988
35 5 p. 747-756
10 p.
artikel
101 Structure-activity relationship of 2-o-ethyl-PAF analogues Ostermann, G.
1988
35 5 p. 844-
1 p.
artikel
102 Studies of the mechanism of candida albicans killing by human epidermal cells: A role for PAF Csato, M.
1988
35 5 p. 797-
1 p.
artikel
103 Studies on the mechanisms of the hemoconcentration produced by PAF and endotoxin in rats Floch, A.
1988
35 5 p. 808-
1 p.
artikel
104 Study of the effect of various drugs toward PAF-induced gastro-intestinal damage in the rat Etienne, A.
1988
35 5 p. 829-
1 p.
artikel
105 Sybergism between Bn 52021, a specific PAF receptor antagonist and somatostatin analogues in anaphylaxis and inflammation Koltai, M.
1988
35 5 p. 850-
1 p.
artikel
106 Synthesis and metabolism of PAF in activated human neutrophils: inhibitory effect of calcium channel blockers nifedipine and verapamil and pertussis toxin Müller, S.
1988
35 5 p. 842-
1 p.
artikel
107 Synthesis and structure-activity relationship of 2,5-diaryltetrahydrofurans as PAF antagonists Biftu, T.
1988
35 5 p. 846-
1 p.
artikel
108 Synthesis of new pyrrolo [1,2-c] thiazole derivatives as potent and specific PAF-antagonists Lavé, D.
1988
35 5 p. 846-
1 p.
artikel
109 Systematic effects of stable analogues of PAF in the rat Hofmann, B.
1988
35 5 p. 825-
1 p.
artikel
110 Tetrahydrofuran derivatives as PAF-acether antagonists - structure-activity relationship Heymans, F.
1988
35 5 p. 845-
1 p.
artikel
111 The contribution of platelets and PAF to allergen-induced late-onset responses and bronchial Page, C.P.
1988
35 5 p. 800-
1 p.
artikel
112 The effect of an orally active leukotriene (LT) D4 antagonist WY-48, 252 on LTD4 and antigen-induced bronchoconstructions in allergic sheep Abraham, W.M.
1988
35 5 p. 733-745
13 p.
artikel
113 The effect of PAF-acether antagonist (BN 52021) on cyclosporine (CsA) nephrotoxicity: glomerular hemodynamic evaluation Santos, OFP.
1988
35 5 p. 811-
1 p.
artikel
114 The effect of PAF antagonists on the hepatic glycogenolysis and diabetes induced by alloxan Hernando, P.
1988
35 5 p. 818-
1 p.
artikel
115 The effect of platelet activating factor and BN52021, a platelet activating antagonist, on the biology of lymphocytes Gebhardt, B.M.
1988
35 5 p. 824-
1 p.
artikel
116 The effect of platelet-activating factor (PAF) antagonists and somatostatin analogues on lymphocytes and natural killer (NK) cell cytotoxicity Farkas, G.
1988
35 5 p. 804-
1 p.
artikel
117 The effects of different platelet activating factor (PAF) antagonists on PAF induced hypotension in the pithed rat English, J.
1988
35 5 p. 825-
1 p.
artikel
118 The effects of specific PAF receptor antagonist BN 52021 on hypoxia-induced spasm of isolated coronary arteries Soloviev, A.I.
1988
35 5 p. 807-
1 p.
artikel
119 The ginkgolide BN-52021 prevents anaphylactic response in guinea-pig Berti, F.
1988
35 5 p. 821-
1 p.
artikel
120 There is a case for PAF-acether antagonists 1988
35 5 p. 781-793
13 p.
artikel
121 The role of a PAF-antagonist in experimental hyperacute rejection (HAR) Makowka, L
1988
35 5 p. 806-
1 p.
artikel
122 The role of platelet activating factor in endotoxemic acute renal failure in the rat Tolins, JP
1988
35 5 p. 812-
1 p.
artikel
123 The VII international conference on “prostaglandins and related compounds” 1988
35 5 p. 651-
1 p.
artikel
124 Thromboxane increases pulmonary vascular resistance and transvascular fluid and protein exchange after pulmonary microembolism Garcia-Szabo, Rene
1988
35 5 p. 707-721
15 p.
artikel
125 Tolerance study, pharmacokinetics and ex vivo PAF-induced platelet aggregation after repeated oral doses of 48740 RP in normal volunteers Pinquier, J.L.
1988
35 5 p. 837-
1 p.
artikel
126 Tumor necrosis factor (TNF) primes platelet activating factor (PAF)-induced superoxide generation by human neutrophils (PMN): Consequences in promoting PMN-mediated endothelial cell (EC) damages Paubert-Braquet, Monique
1988
35 5 p. 803-
1 p.
artikel
127 Use of PAF antagonists to assess the role of PAF in allergen-induced responses of the guinea-pig airway Boubekeur, K.
1988
35 5 p. 799-
1 p.
artikel
128 1989 Winter prostaglandin conference 1988
35 5 p. 652-
1 p.
artikel
                             128 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland